Portugal Pharmaceuticals & Healthcare Q1 2021

Portugal Pharmaceuticals & Healthcare Q1 2021

Key View:

New rules aimed at reducing medicine shortages will increase the burden on pharmaceutical firms to monitor stocklevels and to ensure the supply of medicines in the Portuguese market, thereby limiting their ability to capitalise on price variationsacross the EU. Portugal’s pharmaceutical market will grow over the forecast period, although a repressive pricing environment andweak reimbursement profile will limit its attractiveness when compared to its peers in Western Europe. While public health spendingwill increase over the next few years, private health spending will continue to increase as a share of total health expenditure, asinvestment in public sector facilities remains below demand trends. The growing Portugal-based cannabis medicine industry willdrive investment opportunities.


Key View
Portugal Pharmaceuticals & Healthcare Covid-19 Impact
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Western Europe Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Bial
Bluepharma
Hovione
Medinfar
Portugal Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook